| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.088 | 0.1 |